US Patent 7659277 Ubiquitin ligase inhibitors and methods related thereto
All edits
Edits on 14 Aug, 2024
Golden AI
Edits made to:
Infobox (+1 properties)
Infobox
Edits on 30 Oct, 2023
Golden AI
Edits made to:
Article (+233 characters)
Article
Patent abstract
The application discloses compounds that inhibit ubiquitin ligase activity. The application further discloses antiviral compounds, anticancer compounds, and compounds useful for the treatment of neurological disorders.
Edits on 18 Sep, 2023
Golden AI
Edits made to:
Infobox (+4 properties)
Infobox
Patent Inventor Names
Iris Alroy0
Ofra Levi-Hacham0
Shmuel Tuvia0
Yuval Reiss0
Edits on 24 May, 2023
Golden AI
Edits made to:
Infobox (-1 properties)
Infobox
Official Website
Edits on 18 May, 2023
Golden AI
Edits made to:
Infobox (+1/-1 properties)
US Patent 07659277 Ubiquitin ligase inhibitors and methods related thereto US Patent 7659277 Ubiquitin ligase inhibitors and methods related thereto
Infobox
Patent Number
076592770
Patent Number
76592770
Edits on 23 Sep, 2022
Golden AI
Infobox
Is a
Patent Jurisdiction
Patent Number
076592770
Date of Patent
February 9, 2010
0Patent Application Number
113305000
Date Filed
January 11, 2006
0Official Website
Patent Primary Examiner
Edits on 18 Jun, 2022
Golden AI
Edits made to:
Infobox (+1 properties)
Infobox
Website URL
Edits on 3 Dec, 2021
Golden AI
Edits made to:
Infobox (+7 properties)
US Patent 07659277 Ubiquitin ligase inhibitors and methods related thereto
Infobox
Is a
Patent jurisdiction
Patent number
07659277
Date of patent
February 9, 2010
Patent application number
11330500
Date Filed
January 11, 2006
Patent primary examiner
Find more entities like US Patent 7659277 Ubiquitin ligase inhibitors and methods related thereto
Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.
